Sort
82,697 grants matching “vaccine development”
Nonhuman primate scientific research support component
$3,171,373Sampa Santra · Duke University · UM1 · FY2015 · AI
Development and optimization of a peptide inhibitor of influenza virus splicing for broad-spectrum antiviral therapy
$3,170,096Benjamin R. Tenoever · New York University School Of Medicine · R01 · FY2025 · AI
Nonhuman primate studies for development of a prototype HIV vaccine that induces broadly neutralizing antibodies
$3,169,510Barton F Haynes · Duke University · UM1 · FY2024 · AI
Cross-Protective Humoral Immunity to Coronavirus
$3,169,124Duane R. Wesemann · Brigham And Women'S Hospital · P01 · FY2021 · AI
Immunobioogy for Marrow Allografts for Leukemia
$3,166,828Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2013 · CA
Emory-CDC CTU
$3,165,957Jeffrey Lennox · Emory University · UM1 · FY2022 · AI
Bone Marrow Grafting for Leukemia and Lymphoma
$3,165,316Stanford University · P01 · FY2005 · CA
Discovery of New Innate Immune Pathways in Viral Recognition
$3,165,040Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U19 · FY2016 · AI
Human Dendritic Cells and In Vivo Immunity to Biothreat
$3,164,316Baylor Research Institute · U19 · FY2004 · AI
Discovery of New Innate Immune Pathways in Viral Recognition
$3,163,678Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U19 · FY2014 · AI
Clinical Trials of Parainfluenza and Respiratory Syncytial Virus Vaccines
$3,161,534Brian Murphy · Niaid Extramural Activities · Z01 · FY2007 · AI
CCR Genomics Core
$3,160,426Elizabeth Conner · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
UNC Center for AIDS Research
$3,160,409Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · P30 · FY2010 · AI
ADJUVANT COMPARISON AND CHARACTERIZATION
$3,159,242Bali Pulendran · Stanford University · N01 · FY2024 · AI
Southern California Primary Infection Program
$3,158,919University Of California San Diego · U01 · FY2003 · AI
CHEMOKINE ADJUVANTS FOR BIOTHREAT PATHOGEN VACCINES
$3,157,823Maureen Howard · Chemocentryx, Inc. · U19 · FY2006 · AI
Food & Waterborne Diseases Integrated Research Network
$3,157,811Saul R Tzipori · Tufts University Boston · N01 · FY2009 · AI
NATURAL HISTORY OF AIDS IN HOMOSEXUAL MEN
$3,157,313University Of California Los Angeles · U01 · FY2002 · AI
Protective Mechanisms Against Pandemic Respiratory Virus
$3,156,407Ann M Arvin · Stanford University · U19 · FY2008 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE: UNIVERSAL INFLUENZA RESEARCH ACTIVITIES
$3,156,250Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2021 · AI
IGF::OT::IGF DEVELOPMENT OF BIOPHARMACEUTICALS
$3,151,602Gautam Mitra · Leidos Biomedical Research, Inc. · N01 · FY2016 · CA
Development of vaccines to bacterial diseases found especially in children
$3,151,084John Robbins · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD
cGMP Manufacturing of Glycopeptide Immunogen Nanoparticle Vaccine
$3,150,138Timothy Fouts · Advanced Bioscience Laboratories, Inc. · N01 · FY2019 · AI
Consortium for Viral Systems Biology (CViSB)
$3,150,000Kristian Graugaard Andersen · Scripps Research Institute, The · U19 · FY2019 · AI
Multi-level Optimization of the Cervical Cancer Screening Process in Diverse Settings & Populations (METRICS)
$3,148,326Jasmin Anita Tiro · Ut Southwestern Medical Center · UM1 · FY2020 · CA